MT-401

Drug identity checked against registry records

Also recorded as zedenoleucel

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Efficacy of MT-401 in Patients With AML Following Stem Cell TransplantNCT04511130MRKRPhase 2Terminated2024-03-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.